Both patients and doctors need to understand that these drugs also lower cardiovascular disease outcomes that may be even more important than their weight loss effects since cardiovascular disease is the leading cause of death for persons with diabetes or overweight/obesity (evidence already published for Ozempic showing reduction in cardiovascular events, pending for Wegovy and clinical trials are ongoing for Mounjaro). Type 2 diabetes can be managed
Are There Other Foods Worth Testing by Elimination
As of January 2026, Wegovy is available in two forms: Injection: The original weekly self-administered injection, available in doses from 0.25 mg up to 2.4 mg, with a higher-dose option (Wegovy HD 7.2 mg) also available
[3] Ionescu M, Frohman LA
Double-blind, multicenter trial comparing acetyl L-carnitine with placebo in the treatment of fibromyalgia patients
Of these, only 82 completed a food record, and only 70 completed all three days